EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases.
Ann Rheum Dis
; 82(1): 65-73, 2023 01.
Article
in En
| MEDLINE
| ID: mdl-35551063
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biological Products
/
Rheumatic Diseases
/
Musculoskeletal Diseases
Type of study:
Systematic_reviews
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Ann Rheum Dis
Year:
2023
Type:
Article
Affiliation country:
Netherlands